Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

doi:10.1161/STROKEAHA.117.019216

Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products

Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

研究成果 › 査読

本文言語	English
ページ（範囲）	e145-e152
ジャーナル	Stroke
巻	49
号	4
DOI	https://doi.org/10.1161/STROKEAHA.117.019216
出版ステータス	Published - 4月 1 2018

ASJC Scopus subject areas

臨床神経学
循環器および心血管医学
高度および特殊看護

文献へのアクセス

10.1161/STROKEAHA.117.019216

他のファイルとリンク

引用スタイル

@article{ad9b8153c79d4614a7879fbfe62aa853,

title = "Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products",

keywords = "cell- and tissue-based therapy, cerebral infarction, clinical trial, regenerative medicine, stroke",

author = "\{Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction\} and Kiyohiro Houkin and Hideo Shichinohe and Koji Abe and Teruyo Arato and Mari Dezawa and Osamu Honmou and Nobutaka Horie and Yasuo Katayama and Kohsuke Kudo and Satoshi Kuroda and Tomohiro Matsuyama and Ichiro Miyai and Izumi Nagata and Kuniyasu Niizuma and Ken Sakushima and Masanori Sasaki and Norihiro Sato and Kenji Sawanobori and Satoshi Suda and Akihiko Taguchi and Teiji Tominaga and Haruko Yamamoto and Toru Yamashita and Toshiki Yoshimine",

year = "2018",

month = apr,

day = "1",

doi = "10.1161/STROKEAHA.117.019216",

language = "English",

volume = "49",

pages = "e145--e152",

journal = "Stroke",

issn = "0039-2499",

publisher = "Wolters Kluwer Health",

number = "4",

}

TY - JOUR

T1 - Accelerating Cell Therapy for Stroke in Japan

T2 - Regulatory Framework and Guidelines on Development of Cell-Based Products

AU - Working Group for Guidelines on Development of Cell-Based Products for the Treatment of Cerebral Infarction

AU - Houkin, Kiyohiro

AU - Shichinohe, Hideo

AU - Abe, Koji

AU - Arato, Teruyo

AU - Dezawa, Mari

AU - Honmou, Osamu

AU - Horie, Nobutaka

AU - Katayama, Yasuo

AU - Kudo, Kohsuke

AU - Kuroda, Satoshi

AU - Matsuyama, Tomohiro

AU - Miyai, Ichiro

AU - Nagata, Izumi

AU - Niizuma, Kuniyasu

AU - Sakushima, Ken

AU - Sasaki, Masanori

AU - Sato, Norihiro

AU - Sawanobori, Kenji

AU - Suda, Satoshi

AU - Taguchi, Akihiko

AU - Tominaga, Teiji

AU - Yamamoto, Haruko

AU - Yamashita, Toru

AU - Yoshimine, Toshiki

PY - 2018/4/1

Y1 - 2018/4/1

KW - cell- and tissue-based therapy

KW - cerebral infarction

KW - clinical trial

KW - regenerative medicine

KW - stroke

UR - https://www.scopus.com/pages/publications/85052005856

UR - https://www.scopus.com/pages/publications/85052005856#tab=citedBy

U2 - 10.1161/STROKEAHA.117.019216

DO - 10.1161/STROKEAHA.117.019216

M3 - Review article

C2 - 29581346

AN - SCOPUS:85052005856

SN - 0039-2499

VL - 49

SP - e145-e152

JO - Stroke

JF - Stroke

IS - 4

ER -